402 results on '"Beaugrand, Michel"'
Search Results
2. Perspective on This Article from Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis
3. Data from Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis
4. Supplementary Figures 1 - 2 from Identification of Serum Proton NMR Metabolomic Fingerprints Associated with Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
5. Supplementary Figure 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
6. Data from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
7. Supplementary Table 1 from Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
8. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B
9. Histopathologic Comparison of Monopolar versus No-Touch Multipolar Radiofrequency Ablation to Treat Hepatocellular Carcinoma within Milan Criteria
10. Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan
11. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma
12. Transient elastography in non-alcoholic fatty liver disease
13. Facteur de risque et dépistage du carcinome hépatocellulaire
14. Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease
15. Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
16. Intermediate Hepatobiliary Cells Predict an Increased Risk of Hepatocarcinogenesis in Patients With Hepatitis C Virus-Related Cirrhosis
17. Radiofrequency Ablation with Internally Cooled versus Perfused Electrodes for the Treatment of Small Hepatocellular Carcinoma in Patients with Cirrhosis
18. The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells
19. High Frequency of X Chromosome Abnormalities in Women With Short Stature and Elevated Liver Enzymes
20. Stakeholder perspectives on European priorities for comprehensive liver cancer control: a conjoint analysis
21. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients
22. Manganese Superoxide Dismutase Dimorphism and Iron Overload, Hepatocellular Carcinoma, and Death in Hepatitis C Virus–Infected Patients
23. Diagnosis of heptic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients
24. Who could Benefit from Chemoembolisation?
25. Controlled Attenuation Parameter (CAP) for the detection of hepatic steatosis in alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD): 1506
26. Risk Factors for Hepatocellular Carcinoma in Patients With Alcoholic or Viral C Cirrhosis
27. Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis : A retrospective study of efficacy and cost
28. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
29. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
30. Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
31. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years
32. Telomerase gene mutations are associated with cirrhosis formation
33. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
34. Radiofrequency Ablation Must Be Assessed by Pathological Methods
35. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis#
36. Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis#
37. Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure
38. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B
39. Radiofrequency Ablation for the Treatment of Liver Tumors in the Caudate Lobe
40. Traitement non chirurgical du carcinome hépatocellulaire. Une vision d'ensemble
41. Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis
42. Reply
43. Liver Stiffness Measurement Versus Cliniciansʼ Prediction or Both for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C
44. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases
45. Molecular Epidemiology of Hepatitis C Virus Subtype 3a in Injecting Drug Users
46. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC
47. Significance of Hepatitis B Virus Genotypes A to E in a Cohort of Patients With Chronic Hepatitis B in the Seine Saint Denis District of Paris (France)
48. Local/Regional and Systemic Treatments of Hepatocellular Carcinoma
49. Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death
50. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.